4//SEC Filing
Hansen Shannon Marie 4
Accession 0001628280-25-040841
CIK 0001438133other
Filed
Aug 18, 8:00 PM ET
Accepted
Aug 19, 6:14 PM ET
Size
20.3 KB
Accession
0001628280-25-040841
Insider Transaction Report
Form 4
Hansen Shannon Marie
EVP & Chief Legal Officer
Transactions
- Tax Payment
Common Stock
2025-08-15$10.82/sh−190$2,056→ 17,083 total - Exercise/Conversion
Common Stock
2025-08-15+1,097→ 19,102 total - Exercise/Conversion
Restricted Stock Unit
2025-08-15−531→ 1,061 total→ Common Stock (531 underlying) - Tax Payment
Common Stock
2025-08-15$10.82/sh−393$4,252→ 18,709 total - Exercise/Conversion
Restricted Stock Unit
2025-08-15−1,097→ 7,677 total→ Common Stock (1,097 underlying) - Exercise/Conversion
Restricted Stock Unit
2025-08-15−1,437→ 4,311 total→ Common Stock (1,437 underlying) - Exercise/Conversion
Common Stock
2025-08-15+1,437→ 18,520 total - Exercise/Conversion
Common Stock
2025-08-15+531→ 17,273 total - Tax Payment
Common Stock
2025-08-15$10.82/sh−515$5,572→ 18,005 total
Holdings
- 1,935(indirect: By Trust)
Common Stock
Footnotes (10)
- [F1]Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.
- [F10]RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2025, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
- [F2]The securities are held by the Shannon M. Hansen Trust dated July 8, 2003, of which Shannon M. Hansen is the Trustee.
- [F3]Awarded on February 15, 2022 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).
- [F4]Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.
- [F5]RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 2/15/2023, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.
- [F6]Awarded on May 25, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).
- [F7]Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.
- [F8]RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
- [F9]Awarded on May 23, 2024 pursuant to the 2023 Plan.
Documents
Issuer
TANDEM DIABETES CARE INC
CIK 0001438133
Entity typeother
Related Parties
1- filerCIK 0001908267
Filing Metadata
- Form type
- 4
- Filed
- Aug 18, 8:00 PM ET
- Accepted
- Aug 19, 6:14 PM ET
- Size
- 20.3 KB